Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
Clinical trial NCT02880293 · COMPLETED
Trial details
- NCT number
- NCT02880293
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2023-11-20
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.